构建多参数超声列线图以精准评估乳腺乳头状病变
本回顾性研究分析2017年1月至2023年6月连续住院的176例病理确诊乳腺乳头状病变女性患者,采用灰阶超声、彩色多普勒血流成像和超声造影的多参数超声特征结合临床信息,用二元逻辑回归筛选非典型/恶性病变的独立危险因素并构建列线图。多参数超声联合诊断的AUC为0.966,高于单独灰阶超声(0.869)或彩色多普勒(0.918);包含多参数超声与年龄的列线图预测非典型或恶性乳头状病变的AUC为0.956。
要点
- 年龄≥57岁、超声直径≥13.95 mm、阻力指数≥0.70、超声造影增强范围扩大及造影剂滞留是非典型/恶性乳头状病变的独立预测因素。
- 灰阶超声、彩色多普勒和超声造影联合的多参数超声诊断AUC为0.966,高于单独灰阶超声(0.869)或彩色多普勒(0.918)。
- 超声造影对非肿块型病变预测非典型/恶性的阳性预测值为83.3%。
核心结论
- 多参数超声对预测乳腺乳头状病变恶性高度有效,结合患者年龄构建的列线图(AUC 0.956)为评估恶性风险提供了直观框架。
研究设计与样本
- 回顾性研究,纳入2017年1月至2023年6月连续住院、病理确诊的乳腺乳头状病变女性患者176例,术前行灰阶超声、彩色多普勒血流成像和超声造影检查,回顾性分析超声与临床病理资料,采用二元逻辑回归筛选独立危险因素并构建列线图。
关键影像表现/征象
- 超声造影增强范围扩大和造影剂滞留是非典型/恶性乳头状病变的独立预测因素(OR分别为9.401和5.047)。
- 超声造影对非肿块型病变预测非典型/恶性的阳性预测值为83.3%。
诊断标准与关键数值
- 年龄≥57岁预测非典型/恶性乳头状病变的OR为6.279。
- 超声直径≥13.95 mm预测非典型/恶性乳头状病变的OR为8.078。
- 阻力指数≥0.70预测非典型/恶性乳头状病变的OR为9.246。
- 灰阶超声、彩色多普勒和超声造影联合的多参数超声诊断AUC为0.966,单独灰阶超声AUC为0.869,单独彩色多普勒AUC为0.918。
- 包含多参数超声与患者年龄的列线图预测非典型或恶性乳头状病变的AUC为0.956。
临床应用与阅片要点
- 对乳腺乳头状病变,可综合评估年龄、超声直径、阻力指数及超声造影增强范围扩大和造影剂滞留等特征以辅助判断非典型/恶性风险。
- 超声造影对非肿块型乳头状病变的恶性预测阳性预测值为83.3%,提示其在该类病变评估中具有参考价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To analyze the multi-parametric ultrasonographic (MpUS) features of atypical/malignant papillary lesions of the breast with clinical information, identify independent risk factors, and construct a nomogram to improve the diagnostic accuracy.
METHODS: This retrospective study analyzed consecutively hospitalized patients diagnosed with pathologically confirmed papillary breast lesions from January 2017 to June 2023. Preoperative sonographic examinations, including gray-scale ultrasound (G-US), color Doppler flow imaging (CDFI), and contrast-enhanced ultrasound (CEUS), were conducted. Sonographic scans were retrospectively reviewed alongside clinicopathological data. Binary logistic regression identified independent risk factors for screening atypical/malignant papillary lesions. The receiver operating characteristic curve evaluated the predictive accuracy of these lesions, resulting in the development of a nomogram for assessing risk.
RESULTS: The study involved 176 female patients with breast papillary lesions, identifying key predictors for atypical or malignant outcomes: age 57 or order, US diameter ≥13.95 mm, resistive index ≥0.70, enlarged enhancement on CEUS, and contrast agent retention, with respective odds ratios of 6.279, 8.078, 9.246, 9.401, and 5.047. The integrated use of G-US, CDFI, and CEUS in the MpUS approach offered higher diagnostic accuracy (area under the curve [AUC]: 0.966) than G-US or CDFI alone (0.869/0.918). CEUS particularly enhanced prediction for non-mass-like lesions, with a positive predictive value of 83.3%. A nomogram incorporating MpUS and patient age achieved an AUC of 0.956 for predicting atypical or malignant papillary lesions.
CONCLUSIONS: MpUS imaging is highly effective for predicting malignant breast papillary lesions, especially considering patient age. The nomogram offers an intuitive framework for assessing malignant risk in these lesions.
ADVANCES IN KNOWLEDGE: Ultrasound excels in identifying papillary lesions, and integrating diverse data and multi-parametric imaging enhances malignant risk evaluation. This study establishes a predictive risk model using the nomogram method, demonstrating heightened diagnostic efficacy in breast papillary lesions.
引用
- Li Y, Li H, Du L, et al. Construction of a multi-parametric ultrasonographic nomogram for precise assessment of papillary breast lesions. Br J Radiol. 2025. PMID: 39656793. doi:10.1093/bjr/tqae242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。